HÁLOVÁ, Alice, Laura EWERLINGOVÁ, Tomáš ZEMAN, Jana JANOUTOVÁ, Vladimír JANOUT and Omar ŠERÝ. The relationship between IDE gene polymorphism and Alzheimer's disease. In XIX. setkání biochemiků a molekulárních biologů. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The relationship between IDE gene polymorphism and Alzheimer's disease
Authors HÁLOVÁ, Alice (203 Czech Republic, belonging to the institution), Laura EWERLINGOVÁ (703 Slovakia, belonging to the institution), Tomáš ZEMAN (203 Czech Republic, belonging to the institution), Jana JANOUTOVÁ (203 Czech Republic), Vladimír JANOUT (203 Czech Republic) and Omar ŠERÝ (203 Czech Republic, belonging to the institution).
Edition XIX. setkání biochemiků a molekulárních biologů, 2018.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14310/18:00105134
Organization unit Faculty of Science
Keywords in English Alzheimer's disease; IDE gene; insulin-degrading enzyme; beta amyloid protein
Changed by Changed by: Mgr. Alice Hoffmannová, Ph.D., učo 447156. Changed: 2/1/2019 15:55.
Abstract
Alzheimer’s disease (AD) is a serious neurodegenerative illness related to yearly increasing percentage of affected population. Currently there is no known primary cause of the pathogenesis of AD, and thus it is assumed that it is the interplay of several factors. It can be supposed that heredity also participates in the late-onset AD, but in these cases, there is mostly no comprehensive information about family history due to the high age of patients. For several years, association studies have been trying to find genes that could play a role in increased risk of late onset AD. Studies focused on the molecular mechanisms of Alzheimer’s disease could contribute to an earlier diagnosis and a successful treatment. In our study, we were focused on IDE gene encoding insulin-degrading enzyme, which has a robust capacity to degrade beta amyloid protein, one of the major pathological proteins involved in Alzheimer’s disease pathogenesis. In our research, we examined DNA samples of patients with Alzheimer’s disease and also control subjects, originating from the Czech Republic. Rs2421943 polymorphism of IDE gene was analyzed. For this purpose, the restriction fragment length polymorphism method was used to identify single-nucleotide polymorphism in IDE gene. We found statistically significant association between this polymorphism and the risk of Alzheimer’s disease. Insulin-degrading enzyme can participate in interactions with beta amyloid protein and it can affect the pathogenic processes involved in Alzheimer’s disease.
Links
16-31207A, interní kód MU
(CEP code: NV16-31207A)
Name: Genetika a epidemiologie Alzheimerovy choroby (Acronym: Alzheimer)
Investor: Ministry of Health of the CR
PrintDisplayed: 28/5/2024 10:52